We have been through many phases of DUTV being current and then not being current, so we will just have to wait and see if this current current filing turns into currency for shareholders.
Maybe Garry can actually deliver for us this time...
Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...
Continue Reading
Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...
Continue Reading
A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...
Continue Reading
Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...
Continue Reading
Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...
Continue Reading
A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...
Continue Reading
Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...
Continue Reading
By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...
Continue Reading
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...
Continue Reading
Orchestra BioMed Reports Strong Financial Performance Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO), a pioneering biomedical innovation firm, recently announced notable financial results for the second quarter of 2025. The company has made significant strides in securing over $111 million in proceeds from strategic transactions and concurrent public and private equity...
Continue Reading
Exciting Innovations from Euhomy at CES 2026 CES 2026 is the stage where Euhomy introduces four remarkable portable ice makers. Each model is thoughtfully crafted to suit various occasions, whether it’s a lively outdoor BBQ, an elegant cocktail gathering, or a quiet evening relaxing at home. The Euhomy products are designed to elevate every drink with fresh and...
Continue Reading
When Glass and Medicine Don't Mix Walking a tightrope in pharmaceutical production is no small feat, but American Regent, Inc. just stepped off the safety line with a recall of their Papaverine Hydrochloride Injection. We're talking visible glass and paraformaldehyde floating in those vials like unwelcome party guests. That's a gamble nobody wants to take, especially when...
Continue Reading
AIxCrypto Appoints Andrew Grossman as Head of Legal A recent transformation is underway at AIxCrypto Inc. This innovative company, recognized on the Nasdaq under the ticker AIXC, has elevated its legal operations with the appointment of Andrew Grossman as Head of Legal. Grossman’s role will encompass pivotal responsibilities in legal, compliance, and governance...
Continue Reading
Revolutionary Invention to Combat Urine Leaks An inventor from Maryland has created a new accessory, LAST DROP, specifically designed to absorb urine leaks. The inspiration stemmed from personal experiences with prostate cancer, highlighting the need for improved comfort and hygiene for men dealing with this sensitive issue. Features and Benefits of LAST DROP LAST DROP...
Continue Reading